Ang PCS - Search Results

1

Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients.

Lal S, Sutiman N, Ooi LL, Wong ZW, Wong NS, Ang PCS, Chowbay B. Lal S, et al. Among authors: ang pcs. Pharmacogenomics J. 2017 Jul;17(4):337-343. doi: 10.1038/tpj.2016.17. Epub 2016 Mar 15. Pharmacogenomics J. 2017. PMID: 26975227

2

CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients.

Lal S, Sandanaraj E, Wong ZW, Ang PC, Wong NS, Lee EJ, Chowbay B. Lal S, et al. Cancer Sci. 2008 Oct;99(10):2045-54. doi: 10.1111/j.1349-7006.2008.00903.x. Cancer Sci. 2008. PMID: 19016765 Free PMC article.

3

Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer.

Wong NS, Seah EZh, Wang LZ, Yeo WL, Yap HL, Chuah B, Lim YW, Ang PC, Tai BC, Lim R, Goh BC, Lee SC. Wong NS, et al. Pharmacogenet Genomics. 2011 Nov;21(11):760-8. doi: 10.1097/FPC.0b013e32834a8639. Pharmacogenet Genomics. 2011. PMID: 21849928 Clinical Trial.

4

Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors.

Lim WT, Tan EH, Toh CK, Hee SW, Leong SS, Ang PCS, Wong NS, Chowbay B. Lim WT, et al. Among authors: ang pcs. Ann Oncol. 2010 Feb;21(2):382-388. doi: 10.1093/annonc/mdp315. Epub 2009 Jul 24. Ann Oncol. 2010. PMID: 19633055 Free article. Clinical Trial.

5

Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.

Chan M, Ji SM, Liaw CS, Yap YS, Law HY, Yoon CS, Wong CY, Yong WS, Wong NS, Ng R, Ong KW, Madhukumar P, Oey CL, Tan PH, Li HH, Ang P, Ho GH, Lee AS. Chan M, et al. Breast Cancer Res Treat. 2012 Nov;136(1):209-20. doi: 10.1007/s10549-012-2234-y. Epub 2012 Sep 11. Breast Cancer Res Treat. 2012. PMID: 22965832

6

Detection of a novel Alu-mediated BRCA1 exon 13 duplication in Chinese breast cancer patients and implications for genetic testing.

Yap KP, Ang P, Lim IH, Ho GH, Lee AS. Yap KP, et al. Clin Genet. 2006 Jul;70(1):80-2. doi: 10.1111/j.1399-0004.2006.00637.x. Clin Genet. 2006. PMID: 16813611 No abstract available.

7

Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens.

Dai MS, Feng YH, Chen SW, Masuda N, Yau T, Chen ST, Lu YS, Yap YS, Ang PCS, Chu SC, Kwong A, Lee KS, Ow S, Kim SB, Lin J, Chung HC, Ngan R, Kok VC, Rau KM, Sangai T, Ng TY, Tseng LM, Bryce R, Bebchuk J, Chen MC, Hou MF. Dai MS, et al. Among authors: ang pcs. Breast Cancer Res Treat. 2021 Oct;189(3):665-676. doi: 10.1007/s10549-021-06313-5. Epub 2021 Sep 23. Breast Cancer Res Treat. 2021. PMID: 34553296 Free PMC article. Clinical Trial.

8

A molecular approach for identifying individuals with Li-Fraumeni syndrome who have a limited family history.

Ang P, Lim IH, Yong RY, Lee AS. Ang P, et al. Clin Genet. 2009 Mar;75(3):294-7. doi: 10.1111/j.1399-0004.2008.01133.x. Clin Genet. 2009. PMID: 19250386 No abstract available.

9

Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer.

Gomez HL, Doval DC, Chavez MA, Ang PC, Aziz Z, Nag S, Ng C, Franco SX, Chow LW, Arbushites MC, Casey MA, Berger MS, Stein SH, Sledge GW. Gomez HL, et al. J Clin Oncol. 2008 Jun 20;26(18):2999-3005. doi: 10.1200/JCO.2007.14.0590. Epub 2008 May 5. J Clin Oncol. 2008. PMID: 18458039 Clinical Trial.

10

Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations.

Khor CC, Winter S, Sutiman N, Mürdter TE, Chen S, Lim JSL, Li Z, Li J, Sim KS, Ganchev B, Eccles D, Eccles B, Tapper W, Zgheib NK, Tfayli A, Ng RCH, Yap YS, Lim E, Wong M, Wong NS, Ang PCS, Dent R, Tremmel R, Klein K, Schaeffeler E, Zhou Y, Lauschke VM, Eichelbaum M, Schwab M, Brauch HB, Chowbay B, Schroth W. Khor CC, et al. Among authors: ang pcs. Clin Pharmacol Ther. 2023 Mar;113(3):712-723. doi: 10.1002/cpt.2846. Epub 2023 Jan 31. Clin Pharmacol Ther. 2023. PMID: 36629403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters